Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > Christophe Degois

<< Previous

Bullboard Posts

Next >>

Comment by Peladawnon Aug 01, 2024 9:11am

64 Views

Post# 36157931

RE:RE:RE:RE:RE:RE:Christophe Degois

Noteable.....who cares what "The Guardian" called DT?.....that's supposed to prove something?....that ridiculous slimeball rag has been falsely accusing Trump for years......at least Trump showed up for that interview....where was Kamala?......hiding in her basement away from any serious interviews....that's where!

<< Previous

Bullboard Posts

Next >>

3 Mid-Sized Stocks to Consider This Season